Refine by
Clearside Retinal Therapy Equipment & Supplies
1 equipment items found
Manufactured by:Clearside Biomedical based inAlpharetta, GEORGIA (US) (USA)
Axitinib is a tyrosine kinase inhibitor (TKI) currently approved to treat renal cell cancer that achieves pan-VEGF blockade, directly inhibiting VEGF receptors-1, -2, and -3 with high potency and specificity. We believe this broad VEGF blockade may have efficacy advantages over existing retinal therapies and may benefit patients who sub-optimally respond to ...